Rh-prophylaxis in early abortion

Acta Obstetricia et Gynecologica Scandinavica

Volumn 82, Issue 10, 2003, Pages 892-903

  Fiala, C ^a   Fux, M ^a   Gemzell Danielsson, K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIFEPRISTONE; PROSTAGLANDIN; RHESUS ANTIGEN; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ABORTION; ANTIBODY RESPONSE; ANTIGENICITY; BLOOD GROUP RHESUS SYSTEM; CORRELATION ANALYSIS; EMBRYOLOGY; ERYTHROCYTE; FETOMATERNAL TRANSFUSION; FETUS BLOOD; FETUS CELL; GESTATIONAL AGE; GYNECOLOGY; HEMATOLOGY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; INDUCED ABORTION; MATERNAL BLOOD; MEDICAL SPECIALIST; MEDLINE; MENSTRUAL CYCLE; METHODOLOGY; NEWBORN HEMOLYTIC DISEASE; OBSTETRICS; POPULATION; PREGNANCY; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; PUBLICATION; RACE; REVIEW; RHESUS IMMUNIZATION; RHESUS INCOMPATIBILITY; SECONDARY IMMUNE RESPONSE; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RH-HR BLOOD-GROUP SYSTEM;

EID: 0141426801     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2003.00266.x     Document Type: Review

References (39)

1. Larsen WJ. Human embryology, 2nd edn. New York: Churchill Livingstone, 1997: 223-4.
2. Sadler TW. Langman's medical embryology, 8th edn. Philadelphia: Lippincott Williams & Wilkins, 2000: 96-7.
3. Lee G, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM et al. Wintrobe's clinical hematology, vol 1, 10th edn (Lea & Febiger eds.). Baltimore, MD: Lippincott Williams & Wilkins, 1999: 146-9, 782-5, 1210-30.
4. Filbey D. Ailoimmunization during pregnancy with special emphasis on anti-D. Medical Dissertation, Linköping University, 1995.
5. Gottwall T. Red cell alloimmunization during pregnancy. Medical Dissertation, Linköping University, 1996.
6. Scott JR, DiSaia PJ, Hammond CB, Spellacy WN, eds. Danforth's obstetrics and gynecology, 8th edn. Philadelphia: Lippincott Williams & Wilkins, 1999: 143-4, 366-75.
7. Mollison PL, Engelfield CP, Contreras M. Blood transfusion in clinical medicine, 10th edn. Oxford: Blackwell Science, 2000: 390-418.
8. Cunningham FG, ed. William's obstetrics, 20th edn. Stamford, CT: Prentice Hall International, 1996: 582-3, 982-90.
9. Kochenour NK, Beeson J. The use of Rh-immune globulin. Clin Obstet Gynecol 1982; 25: 1982.
10. Davey MG, Zipursky A. McMaster Conference on Prevention of Rh Immunization 1977. Vox Sang 1979; 36: 50-64.
11. American College of Obstetricians and Gynecologists. Prevention of Rh D alloimmunization. ACOG Practice Bulletin. Int J Gynecol Obstet 1999; 66: 63-70.
12. Bowman J. Controversies in Rh prophylaxis: who needs Rh immune globulin and when should it be given? Am J Obstet Gynecol 1985; 151: 289-94.
13. Westgren M. Alloimmunisering. In: Marsal K, Grennert L, eds. Obstetrisk Öppenvård, 1st edn. Liber, 1998: 184-95.
14. Goldman J, Eckerling B. Prevention of Rh immunization after abortion with anti-Rh(D)-immunoglobulin. Obstet Gynecol 1972; 40: 1972.
15. Leong M, Duby S, Kinch. Fetal-maternal transfusion following early abortion. Obstet Gynecol 1979; 54: 424-6.
16. Bergström H, Nilsson LA, Nilsson L, Ryttinger L. Demonstration of Rh antigens in a 38-day-old fetus. Am J Obstet Gynecol 1967; 99: 130-3.
17. Edwards RF. The place for anti-D globulin abortion. Aust N Z J Obstet Gynaecol 1970; 10: 96-8.
18. Jörgensen J. Foeto-maternel blödning. Medical Dissertation, Köpenhavn, 1975.
19. Ness PM, Baldwin ML, Niebyl JR. Clinical high-risk designation does not predict excess fetal-maternal hemorrhage. Am J Obstet Gynecol 1987; 156: 154-8.
20. Litwak O, Taswell HF, Banner EA, Keith L. Fetal erythrocytes in maternal circulation after spontaneous. J Am Med Assoc 1970; 214: 531.
21. Von Stein Munsick RA, Stiver K, Ryder K. Fetomaternal hemorrhage in threatened abortion. Obstet Gynaecol 1992; 79: 383-6.
22. Socialstyrelsen, The National Board of Health and Welfare. Profylaktisk behandling mot uppkomst av RhD immunisering. Socialstyrelsens Författningssamlig, 1997: 9(M).
23. Messeter L. Rh-profylax eller ej? Läkartidningen 2000; 97: 6030-3.
24. Freda V, Gorman J, Galen R, Treacy N. The threat of Rh immunisation from abortion. Lancet 1970: 147-8.
25. Simonovits I, Timar I, Bajtai G. Rate of Rh immunization after induced abortion. Vox Sang 1980; 38: 161-4.
26. Stewart F, Burnhill M, Bozorgi N. Reduced dose of Rh immunoglobulin following first trimester pregnancy termination. Obstet Gynecol 1978; 51: 1977.
27. Urquart DR, Templeton A. Reduced risk of isoimmunisation in medical abortion. Lancet 1990; 340: 914.
28. Cairns J. Economics of antenatal prophylaxis. Br J Obstet Gynaecol 1998; 104: 19-22.
29. Lichtenberg PM, Borgatta L, Grimes DA, Stubblefield PG, eds. A clinician's guide to medical and surgical abortion. New York, NY: Churchill Livingstone, 1999.
30. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. Transfus Med 1999; 9: 93-7.
31. National Abortion Federation (professional abortion providers in USA and Canada). Clinical policy guidelines 2001.
32. Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion. National evidence-based clinical guideline no. 7. London: RCOG, 2000 (due for review 2003).
33. The Royal College of Obstetricians and Gynaecologists. Use of anti-D immunoglobulin for Rh prophylaxis. www.rcog.org.uk/guidelines/antid.html, 2001.
34. The Royal College of Obstetricians and Gynaecologists UK, The Royal College of Physicians of Edinburgh. Statement from the Consensus Conference on Anti-D Prophylaxis. Vox Sang 1998; 74: 127-8.
35. Belfrage P. Rh-profylax eller ej? Rekommendatiner efterlyses. Läkartidningen 2000; 97: 6014-15.
36. Belfrage P, Nielsen S. Oklart om profylax mot Rh-immunisering. Läkartidningen 1998; 95: 708-10.
37. Queenan JT. Role of Rh immune globulin in induced abortions. Clin Obstet Gynecol 1971; 14: 235-44.
38. Wibble-Kant J, Beer AE. Antepartum Rh immune globulin. Clin Perinatol 1983; 10: 343-55.
39. Mifepristone - investigator's brochure. Laboratories Exelgyn SA (English version), 1999.